These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. (2R*,3S*)-1-[125I]Iodo-2,3-bis(4-hydroxyphenyl)pentane ([125I]iodonorhexestrol) and (2R*,3S*)-1-[77Br]Bromo-2,3-bis(4-hydroxyphenyl)pentane ([77Br]bromonorhexestrol), two gamma-emitting estrogens that show receptor-mediated uptake by target tissues in vivo. Landvatter SW, Katzenellenbogen JA, McElvany KD, Welch MJ. J Med Chem; 1982 Nov; 25(11):1307-12. PubMed ID: 6292424 [Abstract] [Full Text] [Related]
14. 211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation. Larsen RH, Murud KM, Akabani G, Hoff P, Bruland OS, Zalutsky MR. J Nucl Med; 1999 Jul; 40(7):1197-203. PubMed ID: 10405142 [Abstract] [Full Text] [Related]
16. Radiolabeling of fibrinogen using the iodogen technique. Knight LC, Budzynski AZ, Olexa SA. Thromb Haemost; 1981 Oct; 46(3):593-6. PubMed ID: 7314054 [Abstract] [Full Text] [Related]
17. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination. Wilbur DS, Chyan MK, Hamlin DK, Vessella RL, Wedge TJ, Hawthorne MF. Bioconjug Chem; 2007 Oct; 18(4):1226-40. PubMed ID: 17583925 [Abstract] [Full Text] [Related]
18. An in vivo evaluation of I-fibrinogen labeled by four different methods. Coleman RE, Krohn KR, Metzger JM, Welch MJ, Secker-Walker RH, Siegel BA. J Lab Clin Med; 1974 Jun; 83(6):977-82. PubMed ID: 4422243 [No Abstract] [Full Text] [Related]